At a glance
ClinicalIndex Comparison RecordN/ACompleted· 180,000 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Generalized Neonatal Screening for Severe Combined Immunodeficiencies (SCID) by Quantification of TRECs
In Brief
An observational study for Severe Combined Immunodeficiency and Neonatal Screening. Completed, enrolled 180,000 participants across 1 site.
Detailed Summary
The goal of the proposed research is to observe the prevalence and establish the validity of a newborn screening method for severe combined immunodeficiency (SCID). The assay to be used is developed on the basis of PCR quantification of T-cell receptor excision circles (TRECs) that is absent in SCID patients, thus correlating with the disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 2015
Enrollment StartDec 2015
Primary CompletionDec 2020
Study CompletionDec 2021
TodayJul 2026
First PostedOct 29, 2015
Enrollment StartDec 1, 2015
Primary CompletionDec 1, 2020
Study CompletionDec 1, 2021
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 10.7 years ago